Document is current
Any future updates will be listed below
-
Authors
Parikh, Sameer A.
- License Information
-
More Information
Article History
Received: 29 May 2018
Revised: 22 August 2018
Accepted: 17 September 2018
First Online: 3 October 2018
Conflict of interest
: Research funding has been provided to the institution from Pharmacyclics, MorphoSyS, Janssen, AbbVie, and AstraZeneca for clinical studies in which Sameer A. Parikh is a principal investigator. Sameer A. Parikh has also participated in Advisory Board meetings of Pharmacyclics, AstraZeneca, Gilead, and AbbVie (he was not personally compensated for his participation).
